Singh, Sundeep <br/><br/>
The clinical utility and limitations of serum carbohydrate antigen (CA19-9) as a diagnostic tool for pancreatic cancer and cholangiocarcinoma.  [electronic resource] 

 -  Digestive diseases and sciences  Aug 2011 
 - 2491-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1573-2568 
<br/><br/><label>Standard No.: </label>10.1007/s10620-011-1709-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoma--diagnosis<br/>Bile Duct Neoplasms--blood<br/>Bile Ducts, Intrahepatic<br/>Biomarkers, Tumor--blood<br/>CA-19-9 Antigen--blood<br/>Cholangiocarcinoma--blood<br/>Choledocholithiasis--blood<br/>Cholestasis--blood<br/>Female<br/>Humans<br/>Jaundice--blood<br/>Male<br/>Pancreatic Neoplasms--blood<br/>ROC Curve<br/>Retrospective Studies<br/>Sensitivity and Specificity